A New Staging System for Nasopharyngeal Carcinoma Based on Intensity-modulated Radiation Therapy: Results of a Prospective Multicentric Clinical Study

Overview

Journal Oncotarget

Specialty Oncology

Date 2016 Feb 27

PMID 26918446

Citations 11

Authors

Min Kang

Jianxiong Long

Guisheng Li

Haolin Yan

Guosheng Feng

Meilian Liu

Jinxian Zhu

RenSheng Wang

Affiliations

Soon will be listed here.

Abstract

Purpose: To establish a new clinical staging standard for nasopharyngeal carcinoma (NPC), based on intensity-modulated radiotherapy (IMRT), through a prospective multicenter clinical trial.

Experiment Design: 492 NPC patients were selected from six hospitals in the Guangxi Zhuang Autonomous Region, China from January 2006 to December 2009. Kaplan-Meier method was adopted to calculate survival rates. Log-rank test was used to compare survival differences.

Results: According to the seventh edition of the UICC/AJCC staging system, the differences between T1, T2 and T3 are not statistically significant, suggesting that T1, T2 and T3 could be combined as new T1. There were significant differences between all N stages except those of N3a and N3b, suggesting that N3a and N3b could be combined as new N3. Additionally, the overall survival (OS) curves of stages I, II, III and IVa were not significantly different. Therefore, we propose a new clinical NPC staging standard based on magnetic resonance imaging (MRI) and IMRT as T stage (including T1 and T2) , N stage (including N0, N1, N2 and N3) and clinical staging includes I (T1N0M0), II (T1N1-2M0, T2N0M0), III (T2N1-2M0), IVa (TxN3M0) and IVb (TxNxM1). Recommended staging system performs better in risk difference and distribution balance . Furthermore, the differences in the 5-year curves of local relapse-free survival (LRFS), distant metastasis-free survival (DMFS), and OS were all statistically more significant than the seventh edition of the UICC/AJCC staging system.

Conclusions: Proposed staging system is more adaptable to IMRT and predicts the prognosis of NPC patients more accurately.

Citing Articles

Failure Patterns of Recurrence and Metastasis After Intensity-Modulated Radiotherapy in Patients With Nasopharyngeal Carcinoma: Results of a Multicentric Clinical Study.

Chen S, Yang D, Liao X, Lu Y, Yu B, Xu M Front Oncol. 2022; 11:693199.

PMID: 35223448 PMC: 8874804. DOI: 10.3389/fonc.2021.693199.

The Role of Epstein-Barr Virus in Modulating Key Tumor Suppressor Genes in Associated Malignancies: Epigenetics, Transcriptional, and Post-Translational Modifications.

Fierti A, Bright Yakass M, Okertchiri E, Adadey S, Quaye O Biomolecules. 2022; 12(1).

PMID: 35053275 PMC: 8773690. DOI: 10.3390/biom12010127.

Prognostic Factors for Overall Survival in Nasopharyngeal Cancer and Implication for TNM Staging by UICC: A Systematic Review of the Literature.

Chiang C, Guo Q, Ng W, Lin S, Ma T, Xu Z Front Oncol. 2021; 11:703995.

PMID: 34540670 PMC: 8445029. DOI: 10.3389/fonc.2021.703995.

Tumor volume/metabolic information can improve the prognostication of anatomy based staging system for nasopharyngeal cancer? Evaluation of the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer.

Jeong Y, Lee S Radiat Oncol J. 2019; 36(4):295-303.

PMID: 30630268 PMC: 6361247. DOI: 10.3857/roj.2018.00430.

Prognostic significance of Ki67 expression and the derived neutrophil-lymphocyte ratio in nasopharyngeal carcinoma.

Zhao L, Chen H, Hu B, Zhang H, Lin Q Cancer Manag Res. 2018; 10:1919-1926.

PMID: 30013398 PMC: 6038857. DOI: 10.2147/CMAR.S167626.

References

Zeng L, Guo P, Li J, Han F, Li Q, Lu Y . Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy. Oncotarget. 2015; 6(36):39373-83. PMC: 4770779. DOI: 10.18632/oncotarget.5781. View

Zong J, Lin S, Lin J, Tang L, Chen B, Zhang M . Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: Validation of the 7th edition AJCC staging system. Oral Oncol. 2014; 51(3):254-9. DOI: 10.1016/j.oraloncology.2014.10.012. View

Lee A, Foo W, Law S, Poon Y, S K O , Tung S . Staging of nasopharyngeal carcinoma: from Ho's to the new UICC system. Int J Cancer. 1999; 84(2):179-87. DOI: 10.1002/(sici)1097-0215(19990420)84:2<179::aid-ijc15>3.0.co;2-6. View

Lee A, Lau W, Tung S, Chua D, Chappell R, Xu L . Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol. 2005; 23(28):6966-75. DOI: 10.1200/JCO.2004.00.7542. View

Lee A, Sze W, Au J, Leung S, Leung T, Chua D . Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2005; 61(4):1107-16. DOI: 10.1016/j.ijrobp.2004.07.702. View

Heng D, Wee J, Fong K, Lian L, Sethi V, Chua E . Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer. 1999; 86(10):1912-20. View

Chua D, Sham J, Wei W, Ho W, Au G . The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma. Cancer. 2001; 92(11):2845-55. DOI: 10.1002/1097-0142(20011201)92:11<2845::aid-cncr10133>3.0.co;2-7. View

Han L, Lin S, Pan J, Chen C, Zhang Y, Zhang X . Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Chin J Cancer. 2010; 29(2):145-50. DOI: 10.5732/cjc.009.10332. View

Lai S, Li W, Chen L, Luo W, Chen Y, Liu L . How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?. Int J Radiat Oncol Biol Phys. 2010; 80(3):661-8. DOI: 10.1016/j.ijrobp.2010.03.024. View

10.

Chen L, Mao Y, Xie F, Liu L, Sun Y, Tian L . The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China. Radiother Oncol. 2011; 104(3):331-7. DOI: 10.1016/j.radonc.2011.10.009. View

11.

Lin S, Pan J, Han L, Zhang X, Liao X, Lu J . Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys. 2009; 75(4):1071-8. DOI: 10.1016/j.ijrobp.2008.12.015. View

12.

Li A, Xiao W, Shen G, Wang L, Xu A, Cao Y . Distant metastasis risk and patterns of nasopharyngeal carcinoma in the era of IMRT: long-term results and benefits of chemotherapy. Oncotarget. 2015; 6(27):24511-21. PMC: 4695202. DOI: 10.18632/oncotarget.4312. View

13.

Kong F, Ying H, Huang S, Du C, Zhou J, Hu C . Preliminary results of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: a retrospective study of 364 patients. Eur Arch Otorhinolaryngol. 2014; 271(12):3283-90. DOI: 10.1007/s00405-014-2900-2. View

14.

Ng S, Chang T, Ko S, Yen P, Wan Y, Tang L . Nasopharyngeal carcinoma: MRI and CT assessment. Neuroradiology. 1997; 39(10):741-6. DOI: 10.1007/s002340050499. View

15.

Sobin L . TNM: evolution and relation to other prognostic factors. Semin Surg Oncol. 2003; 21(1):3-7. DOI: 10.1002/ssu.10014. View

16.

Pow E, Kwong D, McMillan A, Wong M, Sham J, Leung L . Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys. 2006; 66(4):981-91. DOI: 10.1016/j.ijrobp.2006.06.013. View

17.

Kam M, Leung S, Zee B, Chau R, Suen J, Mo F . Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol. 2007; 25(31):4873-9. DOI: 10.1200/JCO.2007.11.5501. View

18.

El-Sherbieny E, Rashwan H, Lubis S, Choi V . Prognostic factors in patients with nasopharyngeal carcinoma treated in Hospital Kuala Lumpur. Asian Pac J Cancer Prev. 2011; 12(7):1739-43. View

19.

Peng G, Wang T, Yang K, Zhang S, Zhang T, Li Q . A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol. 2012; 104(3):286-93. DOI: 10.1016/j.radonc.2012.08.013. View

20.

Wong F, Ng A, Lee V, Lui C, Yuen K, Sze W . Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2009; 76(1):138-45. DOI: 10.1016/j.ijrobp.2009.01.084. View